• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功使用泊沙康唑治疗接受西罗莫司治疗的肝移植患者的侵袭性皮肤真菌感染。

Successful use of posaconazole to treat invasive cutaneous fungal infection in a liver transplant patient on sirolimus.

机构信息

Department of Internal Medicine, McMaster University;

出版信息

Can J Infect Dis Med Microbiol. 2012 Summer;23(2):e44-7. doi: 10.1155/2012/272197.

DOI:10.1155/2012/272197
PMID:23730320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3403665/
Abstract

Fungi are an important and common cause of cutaneous infections affecting solid organ transplant recipients. These infections can represent a primary site of infection with the potential for dissemination, or a manifestation of metastatic infection. The high morbidity and mortality associated with these infections necessitates urgent therapy with antifungal drugs; however, the interaction between these drugs and immunosuppressive therapies can be a major limitation because of drug toxicity. A case of soft tissue infection of the toe caused by Fusarium chlamydosporum and Candida guilliermondii in a liver transplant patient on sirolimus, who was successfully treated with the new antifungal agent posaconazole, is described. The pharmacokinetic interactions of sirolimus and the new triazoles, and their impact on treatment choices are briefly discussed.

摘要

真菌是导致影响实体器官移植受者的皮肤感染的重要且常见的原因。这些感染可能代表感染的主要部位,并有可能传播,或者表现为转移性感染。这些感染相关的高发病率和死亡率需要用抗真菌药物进行紧急治疗;然而,由于药物毒性,这些药物与免疫抑制治疗之间的相互作用可能是一个主要的限制因素。描述了一例在使用西罗莫司的肝移植患者中,由枝顶孢霉和季也蒙毕赤酵母引起的脚趾软组织感染,该患者成功地用新型抗真菌药物泊沙康唑进行了治疗。简要讨论了西罗莫司与新型三唑类药物的药代动力学相互作用及其对治疗选择的影响。

相似文献

1
Successful use of posaconazole to treat invasive cutaneous fungal infection in a liver transplant patient on sirolimus.成功使用泊沙康唑治疗接受西罗莫司治疗的肝移植患者的侵袭性皮肤真菌感染。
Can J Infect Dis Med Microbiol. 2012 Summer;23(2):e44-7. doi: 10.1155/2012/272197.
2
[Role of anidulafungin in solid organ transplant recipients].阿尼芬净在实体器官移植受者中的作用
Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 14:29-34. doi: 10.1016/s0213-005x(08)76590-x.
3
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.泊沙康唑作为实体器官移植后侵袭性真菌感染患者的挽救治疗药物。
Transplantation. 2008 Sep 27;86(6):791-6. doi: 10.1097/TP.0b013e3181837585.
4
Posaconazole: an extended-spectrum triazole antifungal agent.泊沙康唑:一种广谱三唑类抗真菌药。
Clin Ther. 2007 Sep;29(9):1862-86. doi: 10.1016/j.clinthera.2007.09.015.
5
Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.泊沙康唑:用于真菌感染的预防和治疗。
Semin Respir Crit Care Med. 2015 Oct;36(5):767-85. doi: 10.1055/s-0035-1562902. Epub 2015 Sep 23.
6
Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations.新型抗真菌药物在移植受者侵袭性真菌感染治疗中的作用:艾沙康唑和新型泊沙康唑制剂
J Fungi (Basel). 2015 Oct 15;1(3):345-366. doi: 10.3390/jof1030345.
7
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.抗微生物药物综述:泊沙康唑——一种广谱三唑类抗真菌药
Clin Infect Dis. 2007 Dec 15;45(12):1610-7. doi: 10.1086/523576.
8
Salvage Treatment of Mucormycosis Post-Liver Transplant With Posaconazole During Sirolimus Maintenance Immunosuppression.在西罗莫司维持免疫抑制期间,泊沙康唑对肝移植术后毛霉菌病的挽救治疗
J Pharm Pract. 2017 Apr;30(2):261-265. doi: 10.1177/0897190016628702. Epub 2016 Jul 8.
9
Posaconazole: clinical pharmacology and potential for management of fungal infections.泊沙康唑:临床药理学及真菌感染管理潜力
Expert Rev Anti Infect Ther. 2005 Aug;3(4):467-87. doi: 10.1586/14787210.3.4.467.
10
A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients.泊沙康唑口服液在肺移植受者血清和肺泡腔中的药代动力学分析。
Int J Antimicrob Agents. 2016 Jan;47(1):69-76. doi: 10.1016/j.ijantimicag.2015.09.015. Epub 2015 Nov 1.

引用本文的文献

1
Initial sirolimus dosage recommendations for pediatric patients with mutation-related immunodeficiency disease.针对患有与突变相关免疫缺陷疾病的儿科患者的西罗莫司初始剂量建议。
Front Pharmacol. 2022 Sep 14;13:919487. doi: 10.3389/fphar.2022.919487. eCollection 2022.
2
A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.一种涉及TORC1途径的常见机制可导致两性霉素B在生物膜和浮游酿酒酵母群体中持续存在。
Sci Rep. 2016 Feb 23;6:21874. doi: 10.1038/srep21874.
3
Pharmacologic and clinical evaluation of posaconazole.泊沙康唑的药理学与临床评价
Expert Rev Clin Pharmacol. 2015 May;8(3):321-34. doi: 10.1586/17512433.2015.1034689.
4
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.三唑类药物的治疗药物监测:从加拿大角度进行的需求评估综述和建议。
Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):327-43. doi: 10.1155/2014/340586.

本文引用的文献

1
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.肝移植受者中由镰刀菌属引起的蜂窝织炎和结节性皮肤病变:病例报告
Transplant Proc. 2010 Mar;42(2):599-600. doi: 10.1016/j.transproceed.2010.01.004.
2
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.泊沙康唑与钙调磷酸酶抑制剂和西罗莫司体外抗接合菌的相互作用。
J Antimicrob Chemother. 2010 Apr;65(4):701-3. doi: 10.1093/jac/dkq020. Epub 2010 Feb 3.
3
Effects of oral posaconazole on the pharmacokinetics of sirolimus.泊沙康唑对西罗莫司药代动力学的影响。
Curr Med Res Opin. 2009 Mar;25(3):701-7. doi: 10.1185/03007990802644209.
4
Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.西罗莫司与伏立康唑联合给药:一项评估安全性及适当管理方法的初步研究。
Pharmacotherapy. 2008 Jun;28(6):719-29. doi: 10.1592/phco.28.6.719.
5
New and emerging treatments for fungal infections.真菌感染的新型及新兴治疗方法。
J Antimicrob Chemother. 2008 Jan;61 Suppl 1:i19-30. doi: 10.1093/jac/dkm428.
6
Posaconazole: an extended-spectrum triazole antifungal agent.泊沙康唑:一种广谱三唑类抗真菌药。
Clin Ther. 2007 Sep;29(9):1862-86. doi: 10.1016/j.clinthera.2007.09.015.
7
Fusarium infections in immunocompromised patients.免疫功能低下患者的镰刀菌感染。
Clin Microbiol Rev. 2007 Oct;20(4):695-704. doi: 10.1128/CMR.00014-07.
8
Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.口服泊沙康唑对环孢素和他克莫司药代动力学的影响。
Pharmacotherapy. 2007 Jun;27(6):825-34. doi: 10.1592/phco.27.6.825.
9
Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.影响唑类抗真菌药与某些免疫抑制剂之间药物相互作用的程度及临床意义的因素。
Pharmacotherapy. 2006 Dec;26(12):1730-44. doi: 10.1592/phco.26.12.1730.
10
Invasive fungal infections: a review of epidemiology and management options.侵袭性真菌感染:流行病学与管理选择综述
J Med Microbiol. 2006 Jul;55(Pt 7):809-818. doi: 10.1099/jmm.0.46548-0.